Highly vulnerable patients treated at hospitals accredited by the ACS Commission on Cancer were more likely to receive guideline-based care and less likely to die.
Highly vulnerable patients treated at hospitals accredited by the ACS Commission on Cancer were more likely to receive guideline-based care and less likely to die.